Detection of ICOS<sup>+</sup>T cells by multiplex immunohistochemistry in tumor tissue and its clinical significance in hepatocellular carcinoma

马家强; 曹春梅; 陈　沁; 高　强; 张晓明

doi:10.19401/j.cnki.1007-3639.2019.05.005

您当前的位置：

首页 >

文章列表页 >

Detection of ICOS⁺T cells by multiplex immunohistochemistry in tumor tissue and its clinical significance in hepatocellular carcinoma

更新时间：2026-01-27

- Detection of ICOS⁺T cells by multiplex immunohistochemistry in tumor tissue and its clinical significance in hepatocellular carcinoma
- China Oncology Vol. 29, Issue 5, Pages: 352-361(2019)
- 作者机构：
  
  1. 上海大学生命科学学院,上海,200444
  2. 中国科学院上海巴斯德研究所,上海,200031
  3. 复旦大学附属肿瘤医院肿瘤研究所，复旦大学上海医学院肿瘤学系,上海,200032
  4. 复旦大学附属中山医院肝脏外科,上海,200032
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2019.05.005
  CLC： R735.7
- Published Online：03 June 2019，
  
  Published：03 June 2019
- 稿件说明：
移动端阅览
马家强，曹春梅，Shyamal Goswami,陈　沁，高　强，张晓明. 肝细胞癌组织ICOS+T细胞的多重免疫组织化学检测及其预后价值研究[J]. 中国癌症杂志, 2019, 29(5): 352-361.

马家强, 曹春梅, 陈　沁, et al. Detection of ICOS⁺T cells by multiplex immunohistochemistry in tumor tissue and its clinical significance in hepatocellular carcinoma[J]. China Oncology, 2019, 29(5): 352-361.
马家强，曹春梅，Shyamal Goswami,陈　沁，高　强，张晓明. 肝细胞癌组织ICOS+T细胞的多重免疫组织化学检测及其预后价值研究[J]. 中国癌症杂志, 2019, 29(5): 352-361. DOI： 10.19401/j.cnki.1007-3639.2019.05.005.

马家强, 曹春梅, 陈　沁, et al. Detection of ICOS⁺T cells by multiplex immunohistochemistry in tumor tissue and its clinical significance in hepatocellular carcinoma[J]. China Oncology, 2019, 29(5): 352-361. DOI： 10.19401/j.cnki.1007-3639.2019.05.005.

摘要

背景与目的：诱导共刺激分子（inducible costimulator，ICOS）属于B7-CD28免疫球蛋白超家族成员，表达于活化T细胞表面，在T细胞的激活和免疫应答中发挥重要作用；但目前对于ICOS及ICOS+ T细胞在肝细胞癌（hepatocellular carcinoma，HCC）肿瘤组织中的表达及其意义尚不清楚。该研究旨在测定ICOS、ICOS

T细胞在HCC患者肿瘤组织中的表达情况并探讨其预后价值。方法：应用组织芯片（tissue microarrays，TMAs）和多重免疫组织化学技术（multiplex immunohistochemistry，mIHC）检测2006—2007年在复旦大学附属中山医院接受手术治疗的358例原发性HCC患者肿瘤组织和癌旁组织中ICOS

细胞、ICOS

CD4

及ICOS

CD8

T细胞的浸润密度和ICOS

细胞占CD4

、CD8

T细胞的百分比。应用Kaplan-Meier法和多因素COX回归模型分析上述指标对患者预后的影响。结果：与癌旁组织相比，ICOS

细胞和ICOS

CD4

T细胞在肿瘤组织中浸润数量显著增加（P0.000 1和P=0.009 1），而ICOS

CD8

T细胞则呈相反的降低趋势（P=0.033）；在肿瘤中，ICOS

CD4

T细胞的浸润程度显著高于ICOS

CD8

T细胞。此外，ICOS

CD4

和ICOS

CD8

T细胞占各自T细胞亚群的百分比在肿瘤组织中均显著增加（P均0.000 1）。预后分析发现，肿瘤组织中ICOS

细胞、ICOS

CD4

及ICOS

CD8

T细胞浸润高的患者总生存期（overall surviva

l，OS）更长，多因素分析证实上述指标是HCC的独立预后良好因素。结论：ICOS在HCC患者的肿瘤组织中高表达，且ICOS

细胞、ICOS

CD4

及ICOS

CD8

T细胞是OS的独立预后良好因素，提示上述指标可作为新的HCC预后免疫标志物。

Abstract

Background and purpose: Inducible costimulator (ICOS) is a member of B7-CD28 immunoglobulin superfamily and expressed on the surface of activated T cells

which plays an important role in T cell activation and effector functions. However

the expression pattern and the significance of ICOS and ICOS

T cells in tumor tissue of hepatocellular carcinoma (HCC) are not defined. To this end

the current study was planned to quantitatively detect the expression of ICOS and ICOS

T cells in the tumor tissue of HCC patients and evaluate their clinical significance. Methods: Tissue microarrays (TMAs) and multiplex immunohistochemistry (mIHC) were used to detect the expression levels of ICOS

cells

ICOS+CD4

and ICOS

CD8

T cells in tumor and paracancerous tissues from HCC patients who received surgical treatment in Zhongshan Hospital

Fudan University from 2006 to 2007 (n=358). The clinical prognosis was evaluated by Kaplan-Meier analysis and COX regression analysis. Results: The densities of infiltrating ICOS

and ICOS

CD4

T cells were significantly higher in tumor tissue than in paracancerous tissue (P0.000 1 and P=0.009 1). By contrast

the density of ICOS

CD8

T cells was significantly lower in tumor tissue than in paracancerous tissue (P=0.033). Within the tumor tissue

the density of ICOS

CD4

T cells was significantly higher compared with ICOS

CD8

T cells (P0.000 1). Moreover

the frequencies of ICOS

CD4

and ICOS

CD8

T cells in tumor tissue were significantly higher compared with their counterparts in paracancerous tissue (P0.000 1). Multivariate COX r

egression analysis identified that ICOS

cells

ICOS

CD4

and ICOS

CD8

T cells were independent favorable prognostic indices for overall survival (OS). Conclusion: Tumor infiltrating ICOS

cells are greatly elevated in the tumor tissue of HCC

and their abundance is associated with prolonged OS. Thus

ICOS

cells

ICOS

CD4

and ICOS

CD8

T cells might be used as novel prognostic immune biomarkers for HCC.

关键词

Keywords

references

Views

2153

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Significance of infiltration of M1 tumor-associated macrophages in hepatocellular carcinoma

The expression of programmed death 1 in tumor-infiltrating lymphocytes of hepatocellular carcinoma and its correlation with prognosis

The expression of arginase-2 and its association with proliferation, apoptosis and prognosis of hepatocellular carcinoma

Expression of Golgi glycoprotein 73 and secreted Clusterin in hepatocellular carcinoma

Clinicopathologic features of SMARCA4-deficient pulmonary malignant tumor with an emphasis on the prognosis

Related Author

Feng XIAO

Tonglin XU

Lin ZHU

Jingwen XIAO

Tianqi WU

Chunyan GU

肖　锋

肖静文

Related Institution

Department of Pathology, the Third People's Hospital of Nantong, Affiliated Nantong Hospital Three of Nantong University

Department of Surgery, the Third People’s Hospital of Nantong, Affiliated Nantong Hospital Three of Nantong University

Clinical Medicine, Major of Medical College Nantong University

南通大学附属南通第三医院，南通市第三人民医院病理科

南通大学附属南通第三医院，南通市第三人民医院消化科

AI问答

⁰

Detection of ICOS+T cells by multiplex immunohistochemistry in tumor tissue and its clinical significance in hepatocellular carcinoma

DOI：10.19401/j.cnki.1007-3639.2019.05.005

摘要

Abstract

关键词

Keywords

references

Detection of ICOS⁺T cells by multiplex immunohistochemistry in tumor tissue and its clinical significance in hepatocellular carcinoma